Viread for chronic hepatitis B in adults - Xagena Medical News

The FDA ( Food and Drug Administration ) has approved Viread ( Tenofovir disoproxil fumarate ) for the treatment of chronic hepatitis B, a serious liver disease caused by the hepatitis B virus ( HBV ). Chronic hepatitis B is the leading cause of liver ...

Drug moves toward FDA approval for HIV prevention - Los Angeles Times

The medication is a combination of two older HIV drugs, Emtriva and Viread. Doctors usually prescribe the medications as part of a drug cocktail that makes it harder for the virus to reproduce. Patients with low viral levels have reduced ...

Rectal Microbicide Shows Better Safety in Laboratory Study - AIDSmeds.com HIV/AIDS Treatment News

Laboratory testing of a modified version of the Viread (tenofovir) microbicide gel provides further evidence that it may be safe for rectal use, according to a paper published online ahead of print by the Journal of Antimicrobial Chemotherapy.

FDA Weighs In On Gilead's Crucial Pill - Forbes

The Quad is a once-a-day pill that aims to provide Gilead with a revenue stream that will last beyond the patent expiration of its key drug Viread and its current one-a-day, Atripla. The Quad also represents a real threat to Merck‘s Isentress.

Truvada for HIV prevention backed by advisory panel, FDA may decide by June - CBS News

The medication is a combination of two older HIV drugs, Emtriva and Viread. Doctors usually prescribe it as part of a drug cocktail to repress the virus. Since Truvada is already on the market to manage HIV, some doctors have prescribed it as a ...

Gilead Sciences’ HIV Drugs Clear a Hurdle - Investorplace.com

Quad combines two existing Gilead drugs, Emtriva and Viread, with two experimental — and as yet, unapproved — drugs. If the agency gives final approval of the 4-in-1 drug, Quad would join the ranks of first-line HIV treatments. If approved ...

FDA Set To Review HIV Prevention Drug - RTT News

The medication is a combination of two older HIV drugs, Emtriva and Viread. Some research indicates taking the drug can lower a person's risk of HIV infection. AIDS United and more than a dozen other advocacy groups are urging the FDA to approve Truvada.

FDA Advisory Committee Supports Approval of Gilead's Truvada(R) for Reducing the Risk of Acquiring HIV - CNBC

Important Safety Information about Truvada: WARNINGS: Lactic Acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogs, including Viread(R), a component of Truvada, in combination with other antiretrovirals.

HIV Drug Maker Gilead Sciences Scores Two Wins - Minyanville

Quad is made up two older Gilead drugs -- Viread and Emtriva -- and a couple of experimental treatments. The unapproved medicines are elvitegravir, which is among a new class of drugs known as integrase inhibitors and cobicistat, a booster drug ...